Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
From EUA To Full Approval: CDER, CBER Still Developing Transition Plans
Oct 15 2020
•
By
Derrick Gingery
EUAs are not intended to be permanent and the FDA is encouraging sponsors using the pathway to work toward full approval of their products. • Source: Shutterstock
More from Product Reviews
More from Pink Sheet